Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients.
Campione E, Lambiase S, Gaeta Shumak R, Galluzzo M, Lanna C, Costanza G, Borselli C, Artosi F, Cosio T, Tofani L, Dattola A, Di Daniele F, Bianchi L. Campione E, et al. Among authors: artosi f. Pharmaceuticals (Basel). 2023 Mar 31;16(4):526. doi: 10.3390/ph16040526. Pharmaceuticals (Basel). 2023. PMID: 37111283 Free PMC article.
Mepolizumab induced palmoplantar psoriasis: A case report.
Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Artosi F, et al. World J Clin Cases. 2023 Sep 16;11(26):6154-6158. doi: 10.12998/wjcc.v11.i26.6154. World J Clin Cases. 2023. PMID: 37731552 Free PMC article.
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study).
Orsini D, Caldarola G, Dattola A, Campione E, Bernardini N, Frascione P, De Simone C, Richetta AG, Galluzzo M, Skroza N, Assorgi C, Amore E, Falco GM, Gaeta Shumak R, Artosi F, Maretti G, Potenza C, Bianchi L, Pellacani G, Peris K, Bonifati C, Graceffa D. Orsini D, et al. Among authors: artosi f. J Dermatolog Treat. 2024 Dec;35(1):2319304. doi: 10.1080/09546634.2024.2319304. Epub 2024 Feb 27. J Dermatolog Treat. 2024. PMID: 38413097 Free article.
Preliminary Evidence of Efficacy, Safety, and Treatment Satisfaction with Tirbanibulin 1% Ointment: A Clinical Perspective on Actinic Keratoses.
Campione E, Rivieccio A, Gaeta Shumak R, Costanza G, Cosio T, Lambiase S, Garofalo V, Artosi F, Lozzi F, Freni C, Romeo A, Dika E, Falconi M, Bianchi L. Campione E, et al. Among authors: artosi f. Pharmaceuticals (Basel). 2023 Dec 4;16(12):1686. doi: 10.3390/ph16121686. Pharmaceuticals (Basel). 2023. PMID: 38139813 Free PMC article.